Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities
Launched by THOMAS JEFFERSON UNIVERSITY · Aug 18, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specially designed educational video can help people in vulnerable communities understand lung cancer and the importance of screening. Lung cancer is a serious health issue, especially in African-American and Asian communities, where the rates of this disease and its deaths are higher than in other groups. The goal of the trial is to see if this video can help more people learn about lung cancer and encourage them to get screened, which means checking for cancer before any symptoms appear.
To participate in this trial, you need to be an adult from the African-American, Korean, or Chinese communities and have a history of smoking, lung cancer, or have already been screened for lung cancer. If you're between the ages of 50 and 80 and have smoked regularly, you might also be eligible. Participants will watch the educational video and provide feedback. This study is currently looking for volunteers, and it’s a great opportunity to help improve awareness and screening for lung cancer in your community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • AIM 1: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
- • AIM 2: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
- • AIM 3: Those who are African American, Korean or Chinese, and are eligible for lung cancer screening, based on current screening guidelines: Current or former smokers who are between 50 and 80 years of age and who have smoked at least one pack a day for 20 years or two packs a day for 10 years
- Exclusion Criteria:
- • AIM 1: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
- • AIM 2: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
- • AIM 3: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have a history of smoking; those who have been diagnosed with lung cancer; those who have undergone lung cancer screening in the past
About Thomas Jefferson University
Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Amy R Leader, DrPH, MPH
Principal Investigator
Thomas Jefferson University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported